An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX ® in Patients With Hemophilia B
Condition:   Hemophilia B Interventions:   Genetic: HEMGENIX;   Biological: Factor IX (FIX) Sponsor:   CSL Behring Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)
Condition:   Hemophilia B Intervention:   Genetic: CSL222 (AAV5-hFIXco-Padua) Sponsor:   CSL Behring Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials